Why did they make this change? Apparently, this was a "logical" transition that they had planned to leverage the millions of people's genetic data they had collected. This data can help identify patterns in our DNA to improve our understanding of human health and diseases.
The biotech industry is increasingly embracing cell and gene therapies to provide customised treatments whereby therapies are tailored to an individual's unique genetic makeup. Personalised medicine uses a person's genetic profile to help inform decisions to help prevent, diagnose, treat, and even halt disease progression.
What do you think about this transition and the use of consumer health data?
Further reading:
https://sanogenetics.com/resources/blog/from-lab-to-life-how-genetic-testing-is-transforming-pharma-and-biotech
https://www.biopharmadive.com/news/23andme-ceo-anne-wojcicki-pharma-drug-development/698995/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202023-11-14%20BioPharma%20Dive:%20Emerging%20Biotech%20%5Bissue:56379%5D%20%28draft%29&utm_term=BioPharma%20Dive:%20Emerging%20Biotech
https://link.biopharmadive.com/click/33354714.9320/aHR0cHM6Ly93d3cuYmlvcGhhcm1hZGl2ZS5jb20vbmV3cy8yM2FuZG1lLWNlby1hbm5lLXdvamNpY2tpLXBoYXJtYS1kcnVnLWRldmVsb3BtZW50LzY5ODk5NS8/64d2019a7d94dfa5e304e4e2B1d124db3
https://www.genome.gov/genetics-glossary/Personalized-Medicine
Comments
Post a Comment